Solid Tumors: Investigational Drug THE-0504

We are assessing the safety and tolerability of THE-0504 for patients with solid tumors. This trial aims to understand how well the drug is tolerated by participants.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
UOC Fase I
La Massimina-Casal Lumbroso, Italy
Sponsor: Thena Biotech S.r.l.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.